Synthesis of four-color 3′-O-allyl modified photocleavable fluorescent nucleotides and related methods

US9255292B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9255292-B2
Application numberUS-201113186353-A
CountryUS
Kind codeB2
Filing dateJul 19, 2011
Priority dateOct 31, 2005
Publication dateFeb 9, 2016
Grant dateFeb 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides a process for making 3′-O-allyl-dGTP-PC-Biodopy-FL-510, 3′-O-allyl-dATP-PC-ROX, 3′-O-allyl-dCTP-PC-Bodipy-650 and 3′-O-allyl-dUTP-PC-R6G, and related methods.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for determining the sequence of a single-stranded DNA template comprising the following steps: (A) contacting the single-stranded DNA template with 9° N polymerase in the presence of (i) a primer and (ii) four nucleotide analogues under conditions such that the 9° N polymerase catalyzes DNA synthesis of a DNA extension product which has incorporated at its 3′ end, a nucleotide analogue complementary to, and base-paired with, a nucleotide residue which is not base-paired and is located at the 5′ end of the single-stranded DNA template to be sequenced, wherein each of the four nucleotide analogues comprises: (a) a base selected from the group consisting of adenine, guanine, cytosine, thymine, and uracil, (b) a deoxyribose, (c) a unique fluorophore cleavably attached to each base of the same type base, and (d) a removable chemical moiety bound to the 3′-oxygen of the deoxyribose which blocks further DNA synthesis when it is incorporated into the extension product; and wherein each fluorescent nucleotide analogue when incorporated into the DNA extension product is characterized by a predetermined fluorescence emission wavelength different from the fluorescence emission wavelength of each of the other three fluorescent nucleotide analogues when incorporated into the DNA extension product; (B) removing nucleotide analogues not incorporated into the DNA extension product; (C) determining the identity of the fluorescent nucleotide analogue incorporated into the DNA extension product based upon its characteristic fluorescence emission wavelength; (D) treating the nucleotide analogue incorporated into the DNA extension product so as to remove the chemical moiety bound to the 3′-oxygen of the deoxyribose and cleave the fluorophore from the base; (E) repeating each of steps (A) to (D) to successively determine the identity of the nucleotide analogues incorporated at the 3′ end of each succeeding extension product so synthesized so as to thereby determine the sequence of the single-stranded DNA template. 2. The method of claim 1 , wherein the single-stranded DNA template is bound to a solid substrate. 3. The method of claim 1 , wherein the primer in (A) is a self-priming moiety. 4. The method of claim 1 , wherein in (A) the fluorophore is photocleavably attached to each base of the same type base. 5. The method of claim 4 , wherein all the fluorophores are photocleavably attached to all the bases. 6. The method of claim 1 , wherein in (A) the removable chemical moiety bound to the 3′-oxygen of the deoxyribose is —CH 2 —CH—CH 2 or —CH 2 —O—CH 3 . 7. The method of claim 1 , wherein in (A) the 9° N polymerase is 9° N polymerase (exo-) A485L/Y409V. 8. The method of claim 1 , wherein the treatment in (D) to remove the chemical moiety from the 3′-oxygen is performed in the presence of a palladium (Pd) catalyst. 9. The method of claim 8 , wherein the palladium catalyst is Na 2 PdCl 4 . 10. The method of claim 1 , wherein the treatment in (D) to remove the chemical moiety is performed at about pH 8.8. 11. The method of claim 4 , wherein the treatment in (D) to photocleave the fluorophore from the base comprises light irradiation. 12. The method of claim 1 , wherein the treatment in (D) results in removal of the chemical moiety from the 3′-oxygen and cleavage of the fluorophore from the base substantially concurrently. 13. The method of claim 1 , wherein the treatment in (D) first results in removal of the chemical moiety from the 3′-oxygen and then cleavage of the fluorophore from the base. 14. The method of claim 1 , wherein the treatment in (D) first results in cleavage of the fluorophore from the base and then removal of the chemical moiety from the 3′-oxygen. 15. A method for determining the sequence of a single-stranded RNA template comprising the following steps: (A) contacting the single-stranded RNA template with an RNA polymerase in the presence of (i) a primer and (ii) four nucleotide analogues under conditions such that the RNA polymerase catalyzes RNA synthesis of an RNA extension product which has incorporated at its 3′ end, a nucleotide analogue complementary to, and base-paired with, a nucleotide residue which is not base-paired and is located at the 5′ end of the single-stranded RNA template to be sequenced, wherein each of the four nucleotide analogues comprises: (a) a base selected from the group consisting of adenine, guanine, cytosine, and uracil, (b) a ribose, (c) a unique fluorophore cleavably attached to each base of the same type base, and (d) a removable chemical moiety bound to the 3′-oxygen of the ribose which blocks further RNA synthesis when it is incorporated into the extension product; and wherein each fluorescent nucleotide analogue when incorporated into the RNA extension product is characterized by a predetermined fluorescence emission wavelength different from the fluorescence emission wavelength of each of the other three fluorescent nucleotide analogues when incorporated into the RNA extension product; (B) removing nucleotide analogues not incorporated into the RNA extension product; (C) determining the identity of the fluorescent nucleotide analogue incorporated into the RNA extension product based upon its characteristic fluorescence emission wavelength; (D) treating the nucleotide analogue incorporated into the RNA extension product so as to remove the chemical moiety bound to the 3′-oxygen of the ribose and cleave the fluorophore from the base; (E) repeating each of steps (A) to (D) to successively determine the identity of the nucleotide analogues incorporated at the 3′ end of each succeeding extension product so synthesized so as to thereby determine the sequence of the single-stranded RNA template. 16. The method of claim 15 , wherein the single-stranded RNA template is bound to a solid substrate. 17. The method of claim 15 , wherein the primer in (A) is a self-priming moiety. 18. The method of claim 15 , wherein in (A) the fluorophore is photocleavably attached to each base of the same type base. 19. The method of claim 18 , wherein all the fluorophores are photocleavably attached to all the bases. 20. The method of claim 15 , wherein in (A) the removable chemical moiety bound to the 3′-oxygen of the ribose is —CH 2 —CH═CH 2 or —CH 2 —O—CH 3 . 21. The method of claim 15 , wherein the treatment in (D) to remove the chemical moiety from the 3′-oxygen is performed in the presence of a palladium (Pd) catalyst. 22. The method of claim 21 , wherein the palladium catalyst is Na 2 PdCl 4 . 23. The method of claim 15 , wherein the treatment in (D) to remove the chemical moiety is performed at about pH 8.8. 24. The method of claim 18 , wherein the treatment in (D) to photocleave the fluorophore from the base comprises light irradiation. 25. The method of claim 15 , wherein the treatment in (D) results in removal of the chemical moiety from the 3′-oxygen and cleavage of the fluorophore from the base substantially concurrently. 26. The method of claim 15 , wherein the treatment in (D) first results in removal of the chemical moiety from the 3′-oxygen and then cleavage of the fluorophore from the base. 27. The method of claim 15 , wherein the treatment in (D) first results in cleavage of the fluorophore from the base and then removal of the chemical moiety from the 3′-oxygen. 28. The method of claim 6 ,

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9255292B2 cover?
This invention provides a process for making 3′-O-allyl-dGTP-PC-Biodopy-FL-510, 3′-O-allyl-dATP-PC-ROX, 3′-O-allyl-dCTP-PC-Bodipy-650 and 3′-O-allyl-dUTP-PC-R6G, and related methods.
Who is the assignee on this patent?
Ju Jingyue, Meng Qinglin, Kim Dae H, and 4 more
What technology area does this patent fall under?
Primary CPC classification C07H19/067. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).